NCT02486770View on ClinicalTrials.gov

Study of Single Doses of IV Aerucin in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
BIOLOGICAL

Aerucin 2.0mg/kg

IV Aerucin 2.0 mg/kg over 1 hour

BIOLOGICAL

Aerucin 8.0mg/kg

IV Aerucin 8.0 mg/kg over 1 hour

BIOLOGICAL

Aerucin 20.0 mg/kg

IV Aerucin 20 mg/kg over 1 hour

Trial Locations (1)

21201

SNBL-CPC, Baltimore

Sponsors
All Listed Sponsors
lead

Aridis Pharmaceuticals, Inc.

INDUSTRY